Actinomycin D-Activated RNase L Promotes H2A.X/H2B-Mediated DNA Damage and Apoptosis in Lung Cancer Cells
Background: Chemotherapy is an essential component for comprehensive cancer treatment, while drug resistance usually fails therapy. DNA repair mechanism of cancer cells restrains the efficacy of therapeutics targeting DNA damage. Investigating target-inducing irreversible cell death of cancer cells...
Main Authors: | Huijing Yin, Zhengyu Jiang, Shuoer Wang, Ping Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01086/full |
Similar Items
-
Involvement of Reactive Oxygen Species in the Hepatorenal Toxicity of Actinomycin V In Vitro and In Vivo
by: Fu-juan Jia, et al.
Published: (2020-08-01) -
Actinomycin V Suppresses Human Non-Small-Cell Lung Carcinoma A549 Cells by Inducing G2/M Phase Arrest and Apoptosis via the p53-Dependent Pathway
by: Shi-qi Lin, et al.
Published: (2019-10-01) -
Effect of SDS Micelles on Actinomycin D – DNA Complexes
by: Ana Maria Toader, et al.
Published: (2022-06-01) -
In vitro and in silico evaluations of actinomycin X2and actinomycin D as potent anti-tuberculosis agents
by: Kamal Ahmad Qureshi, et al.
Published: (2023-03-01) -
Actinomycin D for fibrosis management in ophthalmic implant surgery
by: Brietzke Andreas, et al.
Published: (2019-09-01)